HPWM
PFE icon

Highland Private Wealth Management’s Pfizer PFE Stock Holding History

Highland Private Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,201
Closed -$577K – 113
2022
Q3 		$577K Sell
13,201
-953
-7% -$46.3K 0.09% 81
2022
Q2 		$742K Buy
14,154
+979
+7% +$49.9K 0.11% 67
2022
Q1 		$682K Sell
13,175
-283
-2% -$14.7K 0.09% 77
2021
Q4 		$795K Sell
13,458
-2,143
-14% -$106K 0.1% 72
2021
Q3 		$671K Buy
15,601
+6,903
+79% +$306K 0.09% 80
2021
Q2 		$341K Buy
8,698
+238
+3% +$9.26K 0.05% 119
2021
Q1 		$307K Sell
8,460
-122
-1% -$4.33K 0.05% 117
2020
Q4 		$316K Sell
8,582
-861
-9% -$31.6K 0.05% 107
2020
Q3 		$329K Buy
9,443
+233
+3% +$8.17K 0.06% 94
2020
Q2 		$285K Buy
9,210
+54
+0.6% +$1.83K 0.06% 99
2020
Q1 		$283K Sell
9,156
-2,238
-20% -$76.3K 0.08% 90
2019
Q4 		$423K Sell
11,394
-959
-8% -$34.2K 0.1% 74
2019
Q3 		$421K Sell
12,353
-385
-3% -$14K 0.12% 65
2019
Q2 		$523K Buy
12,738
+1,312
+11% +$52.1K 0.15% 61
2019
Q1 		$460K Buy
11,426
+1,188
+12% +$47.6K 0.14% 61
2018
Q4 		$424K Buy
10,238
+697
+7% +$28.9K 0.16% 58
2018
Q3 		$399K Sell
9,541
-783
-8% -$30.1K 0.13% 62
2018
Q2 		$356K Sell
10,324
-54,067
-84% -$1.85M 0.13% 66
2018
Q1 		$2.17M Buy
64,391
+54,532
+553% +$1.87M 1.34% 30
2017
Q4 		$339K Sell
9,859
-23
-0.2% -$784 0.14% 65
2017
Q3 		$334K Buy
9,882
+346
+4% +$11.1K 0.14% 63
2017
Q2 		$304K Buy
9,536
+81
+0.9% +$2.55K 0.15% 58
2017
Q1 		$307K Sell
9,455
-349
-4% -$11K 0.16% 53
2016
Q4 		$302K Sell
9,804
-519
-5% -$15.8K 0.16% 53
2016
Q3 		$332K Buy
10,323
+120
+1% +$4.01K 0.17% 50
2016
Q2 		$341K Buy
10,203
+1,613
+19% +$51.5K 0.19% 44
2016
Q1 		$240K Buy
+8,590
New +$245K 0.14% 59

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Highland Private Wealth Management's PFE Position: Q4 2022 in Review

Highland Private Wealth Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 13,201 shares — an estimated $577K sold.

Highland Private Wealth Management first reported a position in PFE in Q1 2016 and held it in 27 quarters. The position peaked at $2.17M in Q1 2018. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Highland Private Wealth Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Highland Private Wealth Management sold 13,201 Pfizer shares in Q4 2022, an estimated $577K.
  • Highland Private Wealth Management first reported a position in Pfizer in Q1 2016 and held it in 27 quarters.
  • Highland Private Wealth Management's Pfizer position peaked at $2.17M in Q1 2018.
  • 3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.